Cargando…

Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females

INTRODUCTION: Sex-related differences in clinical manifestations and consequences of Parkinson’s disease (PD) have been poorly explored. Better understanding of sexual dimorphism in neurologic diseases such as PD has been announced as a research priority. The aim of our study was to determine indepe...

Descripción completa

Detalles Bibliográficos
Autores principales: Farhadi, Farzaneh, Vosoughi, Kia, Shahidi, Gholam Ali, Delbari, Ahmad, Lökk, Johan, Fereshtehnejad, Seyed-Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295791/
https://www.ncbi.nlm.nih.gov/pubmed/28203083
http://dx.doi.org/10.2147/NDT.S124984
_version_ 1782505498864517120
author Farhadi, Farzaneh
Vosoughi, Kia
Shahidi, Gholam Ali
Delbari, Ahmad
Lökk, Johan
Fereshtehnejad, Seyed-Mohammad
author_facet Farhadi, Farzaneh
Vosoughi, Kia
Shahidi, Gholam Ali
Delbari, Ahmad
Lökk, Johan
Fereshtehnejad, Seyed-Mohammad
author_sort Farhadi, Farzaneh
collection PubMed
description INTRODUCTION: Sex-related differences in clinical manifestations and consequences of Parkinson’s disease (PD) have been poorly explored. Better understanding of sexual dimorphism in neurologic diseases such as PD has been announced as a research priority. The aim of our study was to determine independent sex differences in clinical manifestations and subtypes, psychosocial functioning, quality of life (QoL) and its domains between male and female individuals with PD. PATIENTS AND METHODS: A comprehensive list of demographics, motor symptoms and subtypes, nonmotor features, health-related quality of life (HRQoL), psychosocial functioning and general aspects of daily life was assessed in 157 individuals (108 males and 49 females) with idiopathic PD. In order to control for potential confounding variables, we applied Orthogonal Partial Least Squares – Discriminant Analysis (OPLS-DA) to explore the strength of each feature to discriminate male and female patients with PD. RESULTS: While no sex difference was found in the total Unified Parkinson’s Disease Rating Scale (UPDRS) score and cumulative daily dose of levodopa, females had significantly more severe anxiety (mean difference =2.2 [95% confidence interval, CI: 0.5–4.0], P=0.011), worse nutritional status (23.8 [standard deviation, SD =4.2] vs 25.8 [SD =2.6], P=0.003) and poorer QoL (28.3 [SD =15.7] vs 17.9 [SD =14.2], P<0.001). Based on multivariate discriminant analysis, emotional well-being, bodily discomfort, social support, mobility and communication domains of HRQoL, together with anxiety, depression and psychosocial functioning, were the strongest features with more severe/worse status in females after adjustment for potential statistical confounders. CONCLUSION: Our study provides a comprehensive understanding of sexual dimorphism in PD. Anxiety, depression, specific domains of HRQoL (mobility, emotional well-being, social support and bodily discomfort) and psychosocial functioning were significantly worse in female individuals with PD. Sexual dimorphism in PD highlights the features that are more likely to be affected in each sex and should be specifically targeted when managing male and female individuals with PD.
format Online
Article
Text
id pubmed-5295791
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-52957912017-02-15 Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females Farhadi, Farzaneh Vosoughi, Kia Shahidi, Gholam Ali Delbari, Ahmad Lökk, Johan Fereshtehnejad, Seyed-Mohammad Neuropsychiatr Dis Treat Original Research INTRODUCTION: Sex-related differences in clinical manifestations and consequences of Parkinson’s disease (PD) have been poorly explored. Better understanding of sexual dimorphism in neurologic diseases such as PD has been announced as a research priority. The aim of our study was to determine independent sex differences in clinical manifestations and subtypes, psychosocial functioning, quality of life (QoL) and its domains between male and female individuals with PD. PATIENTS AND METHODS: A comprehensive list of demographics, motor symptoms and subtypes, nonmotor features, health-related quality of life (HRQoL), psychosocial functioning and general aspects of daily life was assessed in 157 individuals (108 males and 49 females) with idiopathic PD. In order to control for potential confounding variables, we applied Orthogonal Partial Least Squares – Discriminant Analysis (OPLS-DA) to explore the strength of each feature to discriminate male and female patients with PD. RESULTS: While no sex difference was found in the total Unified Parkinson’s Disease Rating Scale (UPDRS) score and cumulative daily dose of levodopa, females had significantly more severe anxiety (mean difference =2.2 [95% confidence interval, CI: 0.5–4.0], P=0.011), worse nutritional status (23.8 [standard deviation, SD =4.2] vs 25.8 [SD =2.6], P=0.003) and poorer QoL (28.3 [SD =15.7] vs 17.9 [SD =14.2], P<0.001). Based on multivariate discriminant analysis, emotional well-being, bodily discomfort, social support, mobility and communication domains of HRQoL, together with anxiety, depression and psychosocial functioning, were the strongest features with more severe/worse status in females after adjustment for potential statistical confounders. CONCLUSION: Our study provides a comprehensive understanding of sexual dimorphism in PD. Anxiety, depression, specific domains of HRQoL (mobility, emotional well-being, social support and bodily discomfort) and psychosocial functioning were significantly worse in female individuals with PD. Sexual dimorphism in PD highlights the features that are more likely to be affected in each sex and should be specifically targeted when managing male and female individuals with PD. Dove Medical Press 2017-02-01 /pmc/articles/PMC5295791/ /pubmed/28203083 http://dx.doi.org/10.2147/NDT.S124984 Text en © 2017 Farhadi et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Farhadi, Farzaneh
Vosoughi, Kia
Shahidi, Gholam Ali
Delbari, Ahmad
Lökk, Johan
Fereshtehnejad, Seyed-Mohammad
Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
title Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
title_full Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
title_fullStr Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
title_full_unstemmed Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
title_short Sexual dimorphism in Parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
title_sort sexual dimorphism in parkinson’s disease: differences in clinical manifestations, quality of life and psychosocial functioning between males and females
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295791/
https://www.ncbi.nlm.nih.gov/pubmed/28203083
http://dx.doi.org/10.2147/NDT.S124984
work_keys_str_mv AT farhadifarzaneh sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales
AT vosoughikia sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales
AT shahidigholamali sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales
AT delbariahmad sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales
AT lokkjohan sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales
AT fereshtehnejadseyedmohammad sexualdimorphisminparkinsonsdiseasedifferencesinclinicalmanifestationsqualityoflifeandpsychosocialfunctioningbetweenmalesandfemales